Literature DB >> 18426837

Retinol, retinol-binding protein 4, abdominal fat mass, peak bone mineral density, and markers of bone metabolism in men: the Northern Osteoporosis and Obesity (NO2) Study.

Magnus Högström1, Anna Nordström, Peter Nordström.   

Abstract

CONTEXT: The association between retinol and bone mineral density (BMD) in males after puberty has not been fully investigated previously.
OBJECTIVE: To investigate the association between retinol, retinol-binding protein-4 (RBP-4), BMD (g/cm(2)), abdominal fat mass, and markers of bone metabolism in young men.
DESIGN: Longitudinal study. PARTICIPANTS: Seventy-eight healthy males with a mean age of 22.6+/-0.7 years at baseline. A follow-up was conducted in 73 of the participants 2.0+/-0.4 years later. MAIN OUTCOME MEASURES: Associations between serum concentrations of retinol and RBP-4, and BMD of the total body, lumbar spine, and hip, serum concentrations of osteocalcin, and carboxy terminal telopeptide of type 1 collagen (CTX), were investigated.
RESULTS: Both retinol and RBP-4 showed an inverse relationship with that of osteocalcin (r=-0.23 to -0.25, P<0.05). Levels of RBP-4 (r=0.26, P=0.02) and osteocalcin (r=-0.23, P=0.04) were also related to abdominal fat mass, and the relationship between RBP-4, retinol, and osteocalcin disappeared after adjusting for this influence of abdominal fat mass. Neither retinol nor RBP-4 concentrations were associated with BMD at any site, CTX as baseline, or changes in BMD during the 2-year follow-up period. Levels of RBP-4 showed a strong association with levels of retinol (r=0.61, P<0.001).
CONCLUSION: We found a negative association between the bone formation marker osteocalcin with retinol and RBP-4. The association disappeared when adjusting for the influence of abdominal fat mass. Neither retinol nor RBP-4 were associated with peak BMD in young men.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426837     DOI: 10.1530/EJE-07-0796

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  Retinol binding protein: marker for insulin resistance and inflammation postburn?

Authors:  Robert Kraft; David N Herndon; Gabriela A Kulp; Gabriel A Mecott; Heiko Trentzsch; Marc G Jeschke
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-11       Impact factor: 4.016

2.  Adipokines may mediate the relationship between resting metabolic rates and bone mineral densities in obese women.

Authors:  S Moradi; K Mirzaei; A A Abdurahman; S A Keshavarz
Journal:  Osteoporos Int       Date:  2017-01-23       Impact factor: 4.507

Review 3.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

4.  Time-course changes in bone turnover markers and fat-soluble vitamins after obesity surgery.

Authors:  Fernando Granado-Lorencio; Alberto Simal-Antón; Javier Salazar-Mosteiro; Carmen Herrero-Barbudo; Encarnación Donoso-Navarro; Inmaculada Blanco-Navarro; Belen Pérez-Sacristán
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

Review 5.  Retinol, Retinoic Acid, and Retinol-Binding Protein 4 are Differentially Associated with Cardiovascular Disease, Type 2 Diabetes, and Obesity: An Overview of Human Studies.

Authors:  Thomas Olsen; Rune Blomhoff
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

6.  Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Authors:  Jialing Wu; Xinyu Wu; Zena Chen; Qing Lv; Mingcan Yang; Xuqi Zheng; Qiuxia Li; Yanli Zhang; Qiujing Wei; Shuangyan Cao; Xiaomin Li; Jun Qi; Minjing Zhao; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

7.  The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis.

Authors:  Li Zhang; Yan-Li Cheng; Shuai Xue; Zhong-Gao Xu
Journal:  Dis Markers       Date:  2020-10-02       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.